Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 3046 to 3060 of 8224 results

  1. Interim clinical guideline surveillance process and methods guide 2013 (PMG16)

    This guide outlines the main elements of the interim NICE clinical guideline surveillance process and methodology, which was agreed by the NICE Board in July 2013

  2. Guide to the technology appraisal and highly specialised technologies appeal process (pre June 2023) (PMG18)

    This document concerns the appeal process for the technology appraisal and highly specialised technologies programmes and provides an overview for organisations wishing to lodge an appeal

  3. Guide to the processes of technology appraisal (PMG19)

    This document is one of a series describing the processes and methods that NICE uses to carry out technology appraisals. It focuses on the technology appraisal processes

  4. Evidence summaries: unlicensed and off-label medicines – Interim process statement (PMG2)

    This interim process statement sets out to guide the development of 'Evidence summaries: unlicensed and off-label medicines' (ESUOMs). It provides an overview of the key process principles and describes all stages of development for ESUOMs

  5. Guide to the methods of technology appraisal 2013 (PMG9)

    This guide provides an overview of the principles and methods of health technology assessment and appraisal within the context of the NICE appraisal process

  6. Familial breast cancer. Patient decision aid on taking a medicine to reduce the chance of developing breast cancer for postmenopausal women at moderately increased risk

    Page 1 of 19 Taking a medicine to reduce the chance of developing breast cancer Decision aid for postmenopausal women at moderately increased

  7. Familial breast cancer. Patient decision aid on taking tamoxifen to reduce the chance of developing breast cancer for premenopausal women at high risk

    Page 1 of 11 Taking tamoxifen to reduce the chance of developing breast cancer Decision aid for premenopausal women at high risk Published

  8. Kidney conditions: CKD and SGLT2 inhibitors

    This indicator has been updated and replaced by NICE indicator 322.

    Published
    21 August 2023

  9. Heart failure: beta blockers

    This indicator has been updated and replaced by NICE indicator 317.

    Published
    31 July 2019

  10. Heart Failure: ACEi or ARBs

    This indicator has been updated and replaced by NICE indicator 317.

    Published
    31 August 2019

  11. Weight management: BMI recording (long-term conditions)

    This indicator has been updated and replaced by NICE indicator 320.

    Published
    3 August 2015

  12. Asthma. Patient decision aid on asthma inhalers and climate change (BTS, NICE, SIGN)

    Asthma inhalers and climate change What is this decision aid about? Inhalers are a key part of treating your asthma. The most important thing is that...

  13. Colorectal cancer . Patient decision aid on Lynch syndrome: should I take aspirin to reduce my chance of getting bowel cancer?

    1 Lynch syndrome: should I take aspirin to reduce my chance of getting bowel cancer? Patient decision aid How likely am I to benefit? If you take...

  14. Hypertension in adults. Patient decision aid on how do I control my blood pressure? Lifestyle options and choice of medicines

    1 How do I control my blood pressure? Lifestyle options and choice of medicines Patient decision aid c NICE 2019. All rights reserved. Subject to...

  15. Accessing NHS care and treatment recommended by NICE (ECD4)

    This document contains advice to help you access treatments and care that NICE has recommended